Just in time for the start of the UEFA Euro 2024 kick off in Germany, the Tiefenbacher Group in Hamburg organized its annual football tournament.
This year, more than 200 people (employees and their families) turned up to join the Tiefenbacher Group Football Cup. They spend a wonderful sunny day playing football together, cheering on the team and then rounding off the day with food and drinks.
In a high-scoring competition, the Team Polar Bears ultimately prevailed out of the 5 teams in a dramatic final against Team Lime Legends after a shootout. Congratulations Jens Müller, Paul-Kester Schulz, Birte Wrogemann, Daniel Weizel, Katharina Wolff, Sebastian Kirschberger, Bastian Höger, Hasan Abualruz for winning this year’s Tiefenbacher Cup!!!!
A big thank you to the organizers Ulrike Klingenberg & Florian Herb for the great work and of course a special thanks to all colleagues who helped to organize the Cup this year! We are already looking forward to next year’s tournament.
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com
